Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 38 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 9260718

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  2. US 9260726

    Targeted integration and expression on exogenous nucleic acid sequences

    Sangamo Biosciences, Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  3. US 9259407

    Nanoemulsion therapeutic compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  4. US 9248145

    Two alkylresorcinol synthase genes from sorghum; cloning, expression, transformation and characterization

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  5. US 9248113

    Infusion and injection solution of Levodopa

    Dizlin Medical Design AB · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  6. US 9244082

    Detection and treatment of LRP4-associated neurotransmission disorders

    Georgia Regents Research Institute, Inc. · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  7. EP 2964255

    BEHANDLUNG UND VORBEUGUNG VON REMOTER ISCHÄMISCHER REPERFUSION

    CSL BEHRING GMBH [DE] · Granted Jan 13, 2016 · Expires Jan 8, 2036

    granted

  8. US 9234196

    Compositions and methods for inhibiting expression of transthyretin

    Alnylam Pharmaceuticals, Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  9. US 9228188

    Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression

    Alnylam Pharmaceuticals, Inc. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  10. US 9220706

    Inhibition of leukemic stem cells by PP2A activating agents

    THE UNITED STATES OF AMERICA NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted

  11. US 9212364

    Compositions and methods for inhibiting expression of mutant EGFR gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  12. US 9206421

    Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  13. US 9200282

    Compositions and methods for inhibiting expression of an RNA from west nile virus

    Alnylam Pharmaceuticals, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  14. US 9198948

    Methods of treating depression and other related diseases

    Northwestern University · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  15. US 9198983

    Compositions and methods for inhibiting expression of Mylip/Idol gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  16. US 9192578

    Hot-melt extrusion of modified release multi-particulates

    The Board of Regents of the University of Texas System · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  17. US 9192683

    Methods of treating disease with FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  18. US 9187516

    Compositions and methods for inhibiting expression of a gene from the Ebola virus

    The United States of America as represented by the Secretary of the Army · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  19. US 9186340

    Ischemia/reperfusion protection compositions and methods of using

    Regents of the University of Minnesota · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  20. US 9181306

    Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  21. US 9173957

    FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIIC

    Five Prime Therapeutics, Inc. · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  22. US 9175290

    Compositions and methods for inhibiting expression of TMPRSS6 gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  23. US 9169296

    Expression and assembly of human group C rotavirus-like particles and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  24. US 9169326

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.